INTERIM REPORT FOR THE PERIOD JANUARY 1 – JUNE 30, 2005

Improved profitability and key agreements with AstraZeneca, Nordea and Volvo

First half year 2005 compared with first half year 2004 • Net sales amounted to SEK 325 million (326). • Operating profit amounted to SEK 21 million (15), generating an operating margin of 7% (5). • Profit after tax was SEK 21 million (13), an increase of 62%. • Earnings per share for the period amounted to SEK 0.36 (0.23). • Cash flow from operating activities amounted to SEK 23 million (-22). • Partnership agreement with AstraZeneca. Extended general agreements with Ericsson and Volvo. Important agreements also signed with Gambro, Nordea and Ikanobanken, among others. Second quarter 2005 compared with second quarter 2004 • Net sales for the quarter amounted to SEK 168 million (161). • Operating profit amounted to SEK 11 million (4), or an operating margin of 7% (3). • Profit after tax was SEK 11 million (3). “During the first half year the level of demand has been stable, which has resulted in a good utilization rate. In our efforts to generate a larger share of sales from packaged offerings, we have continued to establish and launch a number of new offerings, of which Integration Competence Center and IT Governance have been the most successful so far,” said Lars Wollung, President and CEO of AcandoFrontec. For more information, please contact Lars Wollung, President and CEO telephone +46 8 699 72 11 Bertil Carlsén, Executive Vice President & CFO telephone +46 8 699 71 31 Jan Rehn, Director of Communications and Investor Relations telephone +46 31 345 32 43 Financial information is also available on our website www.acandofrontec.com